Mutual Pharma Inks $9M Deal To Settle Pay-For-Delay Claims
Mutual Pharmaceutical Co. Inc. has agreed to pay $9 million to settle claims brought by a proposed class of end-payors claiming the company colluded with Pfizer Inc. unit King Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article